Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

43.15 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 Next >
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
From Establishment Labs Holdings Inc.
Via Business Wire
Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (4 Ratings)
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
Exploring Establishment Labs Hldgs's Earnings Expectations
 
Via Benzinga
Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know
 
Via Benzinga
Establishment Labs Hosting Investor Day on June 12
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at Jefferies Global Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
 
Via Benzinga
Establishment Labs Reports First Quarter 2025 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Launches Preservé™
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces CEO Transition
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces $50 Million Registered Direct Offering
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Third Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Publishes 2024 Post Market Surveillance Report
From Establishment Labs Holdings Inc.
Via Business Wire
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.